COVID-19 Information

The CAP accreditation program adds virtual inspections during pandemic

Read More

COVID-19 Updates

Access recent updates on COVID-19

See the Updates

Order PT for 2021 Today

Our proficiency testing (PT) programs help you deliver performance you can measure, accuracy you can trust. Choose from more than 700 programs for 2021.

Rise to the Challenge

"Adjusting to practice and managing my time outside of work were difficult in the beginning. When I first started, I gained a lot of insight on managing my new role from the CAP’s practice management resources and insights from other pathologist who had experienced similar challenges."

Juanita J. Evans, MD, FCAP Ascension Providence Hospital-Southfield, MI

See Our Newest Sars-Co V-2 PT/EQA and Quality Programs

Revised Uterine Cervix Cancer Protocols

Latest News from the CAP

COVID-19 Media Briefing

The College of American Pathologists (CAP) hosted a media briefing on September 1: The Rapidly Changing COVID-19 Testing Landscape: Where We Are/Where We Are Going, the first in a series of virtual briefings. Leading pathologists offered insights and straight talk on: the latest in testing and advocacy efforts; a new survey addressing Americans’ understanding of testing; where we are with testing as schools continue to reopen and athletes may or may not return to sport. The event was also streamed on Facebook Live.

"We know the testing environment changes daily,” said CAP President Patrick Godbey, MD, FCAP, laboratory director, Southeastern Pathology Associates and Southeast Georgia Health System. “As pathologists on the frontlines of testing, we are able to address today’s current challenges, advancements that have been made, and how vital testing is in all areas of life. We continue to advocate for all patients and members of our profession to ensure the best and most timely care and quality of diagnostic results.”

Moderator and panelist Valerie Fitzhugh, MD, FCAP, associate professor and chair (interim), Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School opened up the forum and reinforced the CAP’s commitment to testing. “Just last week, the CDC and FDA amended testing guidelines,” she said. “As pathologists we stand firm on the importance of testing and certainly being tested if people think they have been exposed to someone who has the virus.”